BridgeMD
New treatment option for Ascites
Official title High Dose Albumin in Refractory Ascites
ClinicalTrials.gov ID: NCT05867602
What this study is testing
What is Albumin?
Albumin is an investigational medicine, given as an once-weekly infusion into a vein, being studied as a potential treatment for ascites.
Also referred to as High dose albumin (HA).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Advanced cirrhosis with complications is a serious problem imposing a heavy financial burden on health care system. Moreover, ascites is associated with increase in mortality rates among cirrhotic patients.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years.
- patients diagnosed with liver cirrhosis.
- Refractory ascites which is defined as ascites failing to resolve after maximum tolerable dose of diuretics, and usually require frequent...
You likely can't join if
- Patients \< 18y
- patients with no history of liver cirrhosis
- patients with refractory ascites but have transjagular intrahepatic portosystemic shunts (TIPS) with previous 3 months
- Patients with ascites due to other causes, including cardiac, malignant
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.